Soaring numbers of attention-deficit/hyperactivity disorder diagnoses and prescriptions for stimulants came at the same time as the pharmaceutical industry's noticeably successful effort to increase awareness of the condition and promote drugs for it to parents, educators and doctors, Alan Schwarz writes. Drugmakers are using similar marketing strategies now in the adult ADHD market, which is potentially more profitable, he writes. "The numbers make it look like an epidemic. Well, it's not. It's preposterous," said psychologist Keith Conners.
Published in Brief: